Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Unequal Association of Mouse Allotypes with Antibodies of Different Specificities

View through CrossRef
Summary The experiments were concerned with whether in F1 heterozygous mice the two parental allotypes are expressed in constant proportions among antibody-producing cells or whether their proportions vary from mouse to mouse. Poly-L-alanine and poly-d-alanine were used as non-crossreacting haptenes. Antibody production by individual spleen cells was recorded in a plaque assay procedure for which the poly-alanine haptenes were linked to rabbit antibodies (IgG) against sheep red blood cells, which in turn were attached to sheep red blood cells. The allotypes of antibodies produced by the individual spleen cells were determined by the facilitation reaction employing reciprocal allotype antisera prepared in the parental mouse strains. A wide fluctuation was found from mouse to mouse in the proportions of cells producing antibodies of the two parental allotypes, especially when the “weaker” haptene, poly-L-alanine, was used as the antigenic determinant. The distribution of the allotype ratios as recorded for poly-L-alanine was heterogeneous in the group of mice studied. In mice injected with both poly-D- and poly-L-alanine, the allotype ratios recorded with poly-L-alanine were not correlated with the allotype ratios recorded with poly-D-alanine. The results are interpreted to mean that the cellular determination to produce antibodies of a given specificity, and the decision about which of two allelic chromosome regions will be active, are associated and are transmitted together in cell lines or clones.
Title: Unequal Association of Mouse Allotypes with Antibodies of Different Specificities
Description:
Summary The experiments were concerned with whether in F1 heterozygous mice the two parental allotypes are expressed in constant proportions among antibody-producing cells or whether their proportions vary from mouse to mouse.
Poly-L-alanine and poly-d-alanine were used as non-crossreacting haptenes.
Antibody production by individual spleen cells was recorded in a plaque assay procedure for which the poly-alanine haptenes were linked to rabbit antibodies (IgG) against sheep red blood cells, which in turn were attached to sheep red blood cells.
The allotypes of antibodies produced by the individual spleen cells were determined by the facilitation reaction employing reciprocal allotype antisera prepared in the parental mouse strains.
A wide fluctuation was found from mouse to mouse in the proportions of cells producing antibodies of the two parental allotypes, especially when the “weaker” haptene, poly-L-alanine, was used as the antigenic determinant.
The distribution of the allotype ratios as recorded for poly-L-alanine was heterogeneous in the group of mice studied.
In mice injected with both poly-D- and poly-L-alanine, the allotype ratios recorded with poly-L-alanine were not correlated with the allotype ratios recorded with poly-D-alanine.
The results are interpreted to mean that the cellular determination to produce antibodies of a given specificity, and the decision about which of two allelic chromosome regions will be active, are associated and are transmitted together in cell lines or clones.

Related Results

Characterization of allotypic determinants of murine complement C3.
Characterization of allotypic determinants of murine complement C3.
Abstract Three allotypes of murine complement C3(C3-1 A, -B, -C) have been distinguished on the basis of their isoelectric point (pI) and alloantigenicity. In order ...
Rheumatoid Arthritis – A Gene Transfer Disease
Rheumatoid Arthritis – A Gene Transfer Disease
Sera from patients with rheumatoid arthritis (RA) were from the very start instrumental in detecting and delineating the human immunoglobulin (Ig) allotypes in the Gm system. Knowl...
Human Gm, Km, and Am Allotypes: WHO/IMGT Nomenclature and IMGT Unique Numbering for Immunoinformatics and Therapeutical Antibodies
Human Gm, Km, and Am Allotypes: WHO/IMGT Nomenclature and IMGT Unique Numbering for Immunoinformatics and Therapeutical Antibodies
Human immunoglobulin allotypes are allelic antigenic determinants (or “markers”) determined serologically, classically by hemagglutination inhibition, on the human immunoglobulin (...
ERAP1 allotypes 2 and 10 differentially regulate the immunopeptidome of melanocytes
ERAP1 allotypes 2 and 10 differentially regulate the immunopeptidome of melanocytes
ABSTRACT Endoplasmic reticulum aminopeptidase 1 (ERAP1) is a polymorphic enzyme that shapes the peptide repertoire presented by MHC class I molecules and can regula...
HLA-B15 Peptide Ligands Are Preferentially Anchored at Their C Termini
HLA-B15 Peptide Ligands Are Preferentially Anchored at Their C Termini
Abstract Therapies to elicit protective CTL require the selection of pathogen- and tumor-derived peptide ligands for presentation by MHC class I molecules. Edman ...
Neurophysin in the hypothalamo-neurohypophysial system. I. Production and characterization of monoclonal antibodies
Neurophysin in the hypothalamo-neurohypophysial system. I. Production and characterization of monoclonal antibodies
Seven mouse monoclonal antibodies (IgGs) were produced against rat neurophysins (NPs). Three were specifically directed against vasopressin-associated NP (NP-AVP), and four were sp...
The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
Abstract Introduction Human immunodeficiency virus (HIV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) surface glycoproteins, including shared epitope motifs, sho...
Blood Cross Matching Without Anti-Human Globulin (AHG) and Bovine Serum: A New Interest for an Old Idea
Blood Cross Matching Without Anti-Human Globulin (AHG) and Bovine Serum: A New Interest for an Old Idea
Abstract  Introduction Transfusion medicine promotes the safety of blood transfusions by rigorously testing to eliminate risks of infection and hemolytic. The efficacy (to correct ...

Back to Top